Product News

Share this article:

AstraZeneca's Seroquel XR picked up an indication for the treatment of acute depressive, manic, and mixed episodes of bipolar disorder. The drug is now available in two new tablet strengths: 50 mg and 150 mg.

Takeda's proton pump inhibitor Kapidex received FDA approval for the treatment of heartburn associated with symptomatic non-erosive Gastroesophageal Reflux Disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE. It is now available in US pharmacies in 30mg and 60mg doses.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Panel votes against painkiller

Panel chair Randall Flick said QRxPharma "had not provided sufficient evidence to support a claim that Moxduo is safer than morphine or oxycodone."

Amgen sales rose by 5% in Q1

But demand for Enbrel and Aranesp slipped.

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.